Skip to main content
. 2020 Nov 5;11:606438. doi: 10.3389/fmicb.2020.606438

FIGURE 2.

FIGURE 2

Percentage of (A) Mannheimia haemolytica and (B) Pasteurella multocida isolates in each surveillance study that were resistant to each antimicrobial. 1Minimum inhibitory concentration (MIC) breakpoints defined by Clinical Laboratory Standards Institute (CLSI) guidelines. 2MIC determined by bimodal distribution of MIC coupled with the presence of associated antimicrobial resistance genes. 2Ampicillin, AMP; 2Clindamycin, CLI; 1Chlortetracycline, CTET; 1Danofloxacin, DANO; 1Enrofloxacin, ENRO; 1Florfenicol, 2FFN; Gentamicin, GEN; 2Neomycin, NEO; 2Oxytetracycline, OXY; 2Penicillin, PEN; 2Trimethoprim/sulfamethoxazole, SDM; 2Spectinomycin, SPE; 2Sulfadimethoxine, SXT; 2Tiamulin, TIA; 1Tilmicosin, TIL; 1Ceftiofur, XNL; 1Tulathromycin, TUL; 2Tylosin tartrate, TYLT.